Can a new drug help sickle cell patients walk farther?
NCT ID NCT06023199
Summary
This study is testing if the drug voxelotor can improve physical function in adults with sickle cell disease. Six participants will take the drug for six months, and researchers will measure how far they can walk in six minutes before and after treatment. The goal is to see if the drug helps patients feel stronger and more capable in their daily lives.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SICKLE CELL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Inova Schar Cancer Institute
Falls Church, Virginia, 22042, United States
Conditions
Explore the condition pages connected to this study.